VFEND- voriconazole tablet, film coated 
VFEND- voriconazole injection, powder, lyophilized, for solution 
VFEND- voriconazole powder, for suspension 
Roerig

----------

FDA-Approved Patient Labeling

VFEND® /VEE-fend/

(voriconazole) IV injection, tablets, liquid

Read the Patient Information that comes with VFEND before you start taking it and each time you get a refill. There may be new information. This information does not take the place of talking with your healthcare provider about your condition or treatment.

What is VFEND?

VFEND is a prescription medicine used to treat certain serious fungal infections in your blood and body. These infections are called "aspergillosis," "esophageal candidiasis," "Scedosporium," "Fusarium," and "candidemia".

It is not known if VFEND is safe and effective in children younger than 12 years old.

Who should not take VFEND?

Do not take VFEND if you:

Ask your healthcare provider or pharmacist if you are not sure if you are taking any of the medicines listed above.

Do not start taking a new medicine without talking to your healthcare provider or pharmacist.

What should I tell my healthcare provider before taking VFEND?

Before you take VFEND, tell your healthcare provider if you:

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements.

VFEND may affect the way other medicines work, and other medicines may affect how VFEND works.

Know what medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.

How should I take VFEND?

VFEND oral suspension will be mixed for you by your pharmacist. Do not mix VFEND oral suspension with any other medicine, flavored liquid, or syrup.

What should I avoid while taking VFEND?

What are possible side effects of VFEND?

VFEND may cause serious side effects including:

Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the symptoms listed above.

The most common side effects of VFEND include:

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of VFEND. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store VFEND?

General information about the safe and effective use of VFEND

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use VFEND for a condition for which it was not prescribed. Do not give VFEND to other people, even if they have the same symptoms that you have. It may harm them.

This Patient Information leaflet summarizes the most important information about VFEND. If you would like more information, talk to your healthcare provider. You can ask your healthcare provider or pharmacist for information about VFEND that is written for health professionals.

This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.

What are the ingredients of VFEND?

Active ingredient: voriconazole

Inactive ingredients:

VFEND IV: sulfobutyl ether beta-cyclodextrin sodium

VFEND tablets: lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone, magnesium stearate, and a coating containing hypromellose, titanium dioxide, lactose monohydrate, and triacetin

VFEND oral suspension: colloidal silicon dioxide, titanium dioxide, xanthan gum, sodium citrate dihydrate, sodium benzoate, anhydrous citric acid, natural orange flavor, and sucrose

This Patient Information has been approved by the U.S. Food and Drug Administration.

This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.

Logo

LAB-0311-12.0

February 2015

Revised: 8/2017
Document Id: bf754bd0-c900-4114-84ed-af7152bb539d
Set id: ce3ef5cf-3087-4d92-9d94-9eb8287228db
Version: 33
Effective Time: 20170815
 
Roerig